Crossmark Global Holdings’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.3M Buy
74,452
+1,993
+3% +$161K 0.08% 231
2026
Q1
$5.12M Sell
72,459
-10,380
-13% -$777K 0.08% 250
2025
Q4
$6.54M Buy
82,839
+2,464
+3% +$195K 0.09% 218
2025
Q3
$6.62M Sell
80,375
-33,306
-29% -$2.62M 0.1% 217
2025
Q2
$9.14M Buy
113,681
+1,211
+1% +$93.5K 0.15% 169
2025
Q1
$9.03M Buy
112,470
+6,899
+7% +$574K 0.16% 160
2024
Q4
$8.64M Buy
105,571
+3,153
+3% +$262K 0.16% 155
2024
Q3
$8.45M Sell
102,418
-694
-0.7% -$51.8K 0.15% 167
2024
Q2
$7.24M Sell
103,112
-3,076
-3% -$220K 0.14% 171
2024
Q1
$7.87M Buy
106,188
+15,003
+16% +$1.05M 0.15% 161
2023
Q4
$6.03M Buy
91,185
+34,630
+61% +$2.17M 0.13% 194
2023
Q3
$3.52M Sell
56,555
-4,698
-8% -$293K 0.08% 272
2023
Q2
$3.83M Sell
61,253
-14,623
-19% -$811K 0.08% 261
2023
Q1
$4.4M Sell
75,876
-18,801
-20% -$1.27M 0.1% 229
2022
Q4
$6.85M Sell
94,677
-16,627
-15% -$1.19M 0.17% 153
2022
Q3
$6.76M Sell
111,304
-1,805
-2% -$115K 0.19% 137
2022
Q2
$7.1M Buy
113,109
+4,415
+4% +$292K 0.18% 142
2022
Q1
$7.64M Sell
108,694
-1,437
-1% -$97.2K 0.17% 153
2021
Q4
$6.88M Buy
110,131
+31,215
+40% +$1.96M 0.15% 164
2021
Q3
$4.87M Buy
78,916
+1,904
+2% +$115K 0.11% 200
2021
Q2
$4.61M Buy
77,012
+9,202
+14% +$583K 0.11% 198
2021
Q1
$4.12M Sell
67,810
-14,470
-18% -$799K 0.1% 216
2020
Q4
$3.86M Sell
82,280
-30,879
-27% -$1.34M 0.1% 226
2020
Q3
$4.21M Sell
113,159
-3,838
-3% -$146K 0.12% 189
2020
Q2
$4.27M Buy
116,997
+10,678
+10% +$372K 0.12% 179
2020
Q1
$3.25M Buy
106,319
+564
+0.5% +$25K 0.12% 201
2019
Q4
$5.39M Sell
105,755
-1,257
-1% -$60.7K 0.15% 159
2019
Q3
$5.05M Sell
107,012
-4,171
-4% -$199K 0.15% 168
2019
Q2
$5.52M Buy
111,183
+4,080
+4% +$192K 0.15% 155
2019
Q1
$4.56M Buy
107,103
+2,044
+2% +$90.4K 0.13% 195
2018
Q4
$4.31M Buy
105,059
+10,051
+11% +$431K 0.13% 191
2018
Q3
$4.44M Sell
95,008
-839
-0.9% -$38.3K 0.11% 215
2018
Q2
$4.18M Sell
95,847
-3,140
-3% -$146K 0.11% 218
2018
Q1
$4.54M Sell
98,987
-5,619
-5% -$273K 0.12% 215
2017
Q4
$5.29M Buy
104,606
+5,671
+6% +$299K 0.13% 200
2017
Q3
$5.14M Buy
+98,935
New +$4.82M 0.13% 191
2016
Q3
$5.14M Buy
+111,005
New +$4.17M 0.13% 191

Other funds holding MET

Crossmark Global Holdings's MET Position: Q2 2026 in Review

Crossmark Global Holdings increased its MetLife (MET) stake by 2.8% in Q2 2026, buying an estimated $161K and bringing the position to 74,452 shares worth $6.3M. The position accounts for 0.08% of the portfolio, ranked #231.

Crossmark Global Holdings first reported a position in MET in Q3 2016 and has held it in 37 quarters since. The position peaked at $9.14M in Q2 2025. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Crossmark Global Holdings held 74,452 shares of MetLife worth $6.3M as of Q2 2026.
  • Crossmark Global Holdings bought 1,993 MetLife shares in Q2 2026, an estimated $161K.
  • MetLife made up 0.08% of Crossmark Global Holdings's portfolio in Q2 2026, its #231 holding.
  • Crossmark Global Holdings first reported a position in MetLife in Q3 2016 and has held it in 37 quarters since.
  • Crossmark Global Holdings's MetLife position peaked at $9.14M in Q2 2025.
  • 1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.